Filing Details

Accession Number:
0001062993-18-003527
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-23 20:36:31
Reporting Period:
2018-08-22
Accepted Time:
2018-08-23 20:36:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875622 Biospecifics Technologies Corp BSTC Pharmaceutical Preparations (2834) 113054851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405235 N Mark Wegman C/O Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook NY 11563
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2018-08-22 3,802 $52.71 76,470 No 4 S Direct
Common Stock, $0.001 Par Value Disposition 2018-08-23 4,698 $52.56 71,772 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The selling price of $52.7073 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $52.26 to $53.14. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. The selling price of $52.5604 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.02 to $52.82. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.